BioVirtus is a full-service early phase clinical sites' network located in Poland (CEE). BioVirtus provides international pharmaceutical and biotech customers with comprehensive, cost effective, and FDA/EMA compliant early clinical studies. Services include: study design and medical writing, recruitment of subjects and patients, clinical conduct in dedicated site located near Warsaw (45 beds), electronic data capture, data processing and reporting. BioVirtus expertise include: > First-in-Man > Phase I/II healthy & patients, various indications > Special populations > Proof-of-Concept > Bioequivalence > Bioavailability > Food effect > PK/PD studies > Biosimilars > Therapeutic equivalence > Nicotine risk evaluation & smoking-cessation studies. www.biovirtus.eu